NO20034538L - Anvendelsen av enantiomer ren escitalopram - Google Patents

Anvendelsen av enantiomer ren escitalopram

Info

Publication number: NO20034538L
Authority: NO; Norway
Prior art keywords: enantiomeric pure; pure escitalopram; escitalopram; enantiomeric; pure
Prior art date: 2001-05-01

Application number

NO20034538A

Other languages

English (en)

Other versions

NO20034538D0 (no

Inventor

Connie Sanchez

Arne Mork

Jesper Lyng Jensen

Original Assignee

Lundbeck & Co As H

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-05-01

Filing date

2003-10-09

Publication date

2003-10-09

2003-10-09 Application filed by Lundbeck & Co As H filed Critical Lundbeck & Co As H

2003-10-09 Publication of NO20034538L publication Critical patent/NO20034538L/no

2003-10-09 Publication of NO20034538D0 publication Critical patent/NO20034538D0/no

Links

WSEQXVZVJXJVFP-FQEVSTJZSA-N escitalopram Chemical compound C1([C@]2(C3=CC=C(C=C3CO2)C#N)CCCN(C)C)=CC=C(F)C=C1 WSEQXVZVJXJVFP-FQEVSTJZSA-N 0.000 title 1
229960004341 escitalopram Drugs 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/87—Benzo [c] furans; Hydrogenated benzo [c] furans
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Bioinformatics & Cheminformatics (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Medicinal Chemistry (AREA)
Engineering & Computer Science (AREA)
Biomedical Technology (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Psychiatry (AREA)
Epidemiology (AREA)
Pain & Pain Management (AREA)
Hematology (AREA)
Obesity (AREA)
Addiction (AREA)
Diabetes (AREA)
Child & Adolescent Psychology (AREA)
Hospice & Palliative Care (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Hydrogenated Pyridines (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

NO20034538A 2001-05-01 2003-10-09 Anvendelsen av enantiomer ren escitalopram NO20034538D0 (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
DKPA200100684		2001-05-01
PCT/DK2002/000281 WO2002087566A1 (en)	2001-05-01	2002-05-01	The use of enantiomeric pure escitalopram

Publications (2)

Publication Number	Publication Date
NO20034538L true NO20034538L (no)	2003-10-09
NO20034538D0 NO20034538D0 (no)	2003-10-09

Family

ID=8160464

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20034538A NO20034538D0 (no)	2001-05-01	2003-10-09	Anvendelsen av enantiomer ren escitalopram

Country Status (25)

Country	Link
US (7)	US20040198809A1 (no)
EP (1)	EP1385503A1 (no)
JP (1)	JP2004527551A (no)
KR (2)	KR20100012089A (no)
CN (1)	CN1509169A (no)
AR (1)	AR033308A1 (no)
AT (1)	AT10974U1 (no)
BG (1)	BG108379A (no)
BR (1)	BR0208283A (no)
CA (1)	CA2445843A1 (no)
CZ (1)	CZ20033267A3 (no)
EA (1)	EA200301195A1 (no)
HR (1)	HRP20030744A2 (no)
HU (1)	HUP0400054A3 (no)
IL (1)	IL158031A0 (no)
IS (1)	IS6954A (no)
ME (1)	MEP5908A (no)
MX (1)	MXPA03008777A (no)
NO (1)	NO20034538D0 (no)
PL (1)	PL367480A1 (no)
SK (1)	SK14612003A3 (no)
UA (1)	UA82828C2 (no)
WO (1)	WO2002087566A1 (no)
YU (1)	YU85303A (no)
ZA (1)	ZA200307102B (no)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AR021155A1 (es) *	1999-07-08	2002-06-12	Lundbeck & Co As H	Tratamiento de desordenes neuroticos
CZ20033267A3 (en) *	2001-05-01	2004-06-16	H. Lundbeck A/S	The use of enantiomeric pure escitalopram
WO2004056791A1 (en) *	2002-12-23	2004-07-08	H. Lundbeck A/S	Escitalopram hydrobromide and a method for the preparation thereof
US20050037983A1 (en) *	2003-03-11	2005-02-17	Timothy Dinan	Compositions and methods for the treatment of depression and other affective disorders
AR047553A1 (es) *	2003-07-04	2006-01-25	Lundbeck & Co As H	La combinacion de un inhibidor de reabsorcion de serotonina y agomelatina
PL1691811T3 (pl) *	2003-12-11	2014-12-31	Sunovion Pharmaceuticals Inc	Skojarzenie leku uspokajającego i modulatora neuroprzekaźnikowego oraz sposoby poprawy jakości snu i leczenia depresji
BRPI0508266A (pt) *	2004-03-05	2007-07-31	Lundbeck & Co As H	partìculas cristalinas de oxalato de escitalopram, forma de dosagem única sólida, e, métodos para a fabricação de partìculas cristalinas de oxalato de escitalopram e para reduzir a quantidade de hidroxila que contém impurezas no citalopram, escitalopram ou uma mistura não racêmica de r- e s-citalopram
US20050196453A1 (en)	2004-03-05	2005-09-08	H. Lundbeck A/S	Crystalline composition containing escitalopram
TWI347942B (en) *	2005-06-22	2011-09-01	Lundbeck & Co As H	Crystalline base of escitalopram and orodispersible tablets comprising escitalopram base
US20070112075A1 (en) *	2005-10-14	2007-05-17	Forest Laboratories, Inc.	Stable pharmaceutical formulations containing escitalopram and bupropion
US7569605B2 (en) *	2005-10-14	2009-08-04	Forest Laboratories Holdings Limited	Methods of treating central nervous system disorders with a low dose combination of escitalopram and bupropion
US20070134322A1 (en) *	2005-12-14	2007-06-14	Forest Laboratories, Inc.	Modified and pulsatile release pharmaceutical formulations of escitalopram
CN100353939C (zh) *	2006-01-05	2007-12-12	昆明积大制药有限公司	含西酞普兰和环糊精的抗抑郁口服药用组合物
US20070259952A1 (en) *	2006-05-02	2007-11-08	H. Lundbeck A/S	Uses of escitalopram
TW200812993A (en) *	2006-05-02	2008-03-16	Lundbeck & Co As H	New uses of escitalopram
US8252336B2 (en) *	2006-10-20	2012-08-28	Ratiopharm Gmbh	Escitalopram and solid pharmaceutical composition comprising the same
JP5404048B2 (ja) *	2006-10-27	2014-01-29	久光製薬株式会社	貼付剤
EP2017271A1 (en)	2007-07-06	2009-01-21	Aurobindo Pharma Limited	Process for the preparation of escitalopram
MY157192A (en) *	2007-08-03	2016-05-13	Richter Gedeon Nyrt	Pharmaceutical compositions containing dopamine receptor ligands and methods of treatment using dopamine receptor ligands
US20100331402A1 (en) *	2008-01-31	2010-12-30	Takeda Pharmaceutical Company Limited	Prophylactic or therapeutic agent for attention deficit/hyperactivity disorder
ITMI20080768A1 (it) *	2008-04-24	2009-10-25	Abiogen Pharma Spa	Procedimento per la preparazione di un composto in forma cristallina di 3-benzil-2-metil-2,3,3a,4,5,6,7,7a-ottaidro-benzo[d]isossazol-4-one
WO2010098230A1 (ja) *	2009-02-27	2010-09-02	久光製薬株式会社	経皮投与製剤
US20180071269A1 (en)	2015-08-12	2018-03-15	Tianxin Wang	Therapeutical methods, formulations and nutraceutical formulations
EP3294337B1 (en) *	2015-05-13	2024-12-18	Arvid Carlsson Research AB	Treatment of debilitating fatigue by combined use of 3(s)-3-[3-(methylsulfonyl)phenyl]-1- propylpiperidine and an anti-depressive agent

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB1143703A (no) *	1965-03-18
US4079135A (en) *	1973-12-13	1978-03-14	Imperial Chemical Industries Limited	Morpholine derivatives as antidepressants
GB1526331A (en) *	1976-01-14	1978-09-27	Kefalas As	Phthalanes
GB8419963D0 (en) *	1984-08-06	1984-09-12	Lundbeck & Co As H	Intermediate compound and method
GB8607313D0 (en) *	1986-03-25	1986-04-30	Ici Plc	Pharmaceutical compositions
GB8814057D0 (en) *	1988-06-14	1988-07-20	Lundbeck & Co As H	New enantiomers & their isolation
US4902710A (en) *	1988-12-14	1990-02-20	Eli Lilly And Company	Serotonin and norepinephrine uptake inhibitors
US5114976A (en) *	1989-01-06	1992-05-19	Norden Michael J	Method for treating certain psychiatric disorders and certain psychiatric symptoms
US4962128A (en) *	1989-11-02	1990-10-09	Pfizer Inc.	Method of treating anxiety-related disorders using sertraline
US5296507A (en) *	1990-09-06	1994-03-22	H.Lundbeck A/S	Treatment of cerbrovascular disorders
US5708035A (en) *	1991-02-04	1998-01-13	Sepracor Inc.	Methods of use and compositions of R(-) fluoxetine
EP0714663A3 (en) *	1994-11-28	1997-01-15	Lilly Co Eli	Potentiation of drug responses by serotonin 1A receptor antagonists
US5627196A (en) *	1995-01-17	1997-05-06	Eli Lilly And Company	Compounds having effects on serotonin-related systems
US5554383A (en) *	1995-04-06	1996-09-10	Trustees Of Tufts College	Veterinary method for clinically modifying the behavior of dogs exhibiting canine affective aggression
SE9501567D0 (sv) *	1995-04-27	1995-04-27	Astra Ab	A new combination
US5846982A (en) *	1996-06-14	1998-12-08	Eli Lilly And Company	Inhibition of serotonin reuptake
US5747494A (en) *	1996-06-28	1998-05-05	U C B S.A.	Pharmaceutical compositions for the treatment of depressive disorders
US5958429A (en) *	1996-08-16	1999-09-28	Eli Lilly And Company	Potentiation of serotonin response
ZA977967B (en) *	1996-09-23	1999-03-04	Lilly Co Eli	Combination therapy for treatment of psychoses
US5776969A (en) *	1997-02-27	1998-07-07	Eli Lilly And Company	Treatment of sleep disorders
US6069177A (en) *	1997-07-08	2000-05-30	The Hong Kong University Of Science And Technology	3-Hydroxy-propanamine derived neuronal reuptake inhibitors
SE9703375D0 (sv) *	1997-09-18	1997-09-18	Astra Ab	A new combination
HUP0002953A3 (en) *	1997-11-11	2002-12-28	Lundbeck & Co As H	Method for preparation of citalopram and intermediates used for them
US6353008B1 (en) *	1998-06-30	2002-03-05	Eli Lilly And Company	Pyrrolidine and pyrroline derivatives having effects on serotonin related systems
US6150376A (en) *	1998-08-05	2000-11-21	Georgetown University	Bi- and tri-cyclic aza compounds and their uses
DE69904853T2 (de) *	1998-10-20	2003-09-04	Lundbeck As Valby H	Verfahren zur herstellung von citalopram
TR200102957T2 (tr) *	1999-04-14	2004-12-21	H. Lundbeck A/S	Sitalopram hazırlanması için metod.
AR021155A1 (es) *	1999-07-08	2002-06-12	Lundbeck & Co As H	Tratamiento de desordenes neuroticos
US6333357B1 (en) *	1999-11-05	2001-12-25	Be Able, Llc	Behavior chemotherapy
UA77650C2 (en) *	1999-12-06	2007-01-15	Lundbeck & Co As H	Use of serotonin reuptake inhibitor in combination with deramcyclane
GB2357762B (en) *	2000-03-13	2002-01-30	Lundbeck & Co As H	Crystalline base of citalopram
AU2001255654B2 (en) *	2000-04-24	2005-09-22	Aryx Therapeutics	Materials and methods for the treatment of depression
CZ20033267A3 (en) *	2001-05-01	2004-06-16	H. Lundbeck A/S	The use of enantiomeric pure escitalopram

2002
- 2002-05-01 CZ CZ20033267A patent/CZ20033267A3/cs unknown
- 2002-05-01 PL PL02367480A patent/PL367480A1/xx not_active Application Discontinuation
- 2002-05-01 IL IL15803102A patent/IL158031A0/xx unknown
- 2002-05-01 CN CNA028092309A patent/CN1509169A/zh active Pending
- 2002-05-01 EA EA200301195A patent/EA200301195A1/ru unknown
- 2002-05-01 MX MXPA03008777A patent/MXPA03008777A/es unknown
- 2002-05-01 HR HR20030744A patent/HRP20030744A2/xx not_active Application Discontinuation
- 2002-05-01 KR KR1020097027003A patent/KR20100012089A/ko not_active Ceased
- 2002-05-01 CA CA002445843A patent/CA2445843A1/en not_active Abandoned
- 2002-05-01 UA UA2003098415A patent/UA82828C2/xx unknown
- 2002-05-01 JP JP2002584912A patent/JP2004527551A/ja active Pending
- 2002-05-01 BR BR0208283-7A patent/BR0208283A/pt not_active IP Right Cessation
- 2002-05-01 ME MEP-59/08A patent/MEP5908A/xx unknown
- 2002-05-01 KR KR10-2003-7014286A patent/KR20040030609A/ko not_active Ceased
- 2002-05-01 WO PCT/DK2002/000281 patent/WO2002087566A1/en not_active Ceased
- 2002-05-01 HU HU0400054A patent/HUP0400054A3/hu unknown
- 2002-05-01 YU YU85303A patent/YU85303A/sh unknown
- 2002-05-01 US US10/468,685 patent/US20040198809A1/en not_active Abandoned
- 2002-05-01 EP EP02724141A patent/EP1385503A1/en not_active Withdrawn
- 2002-05-01 SK SK1461-2003A patent/SK14612003A3/sk not_active Application Discontinuation
- 2002-05-02 AR ARP020101612A patent/AR033308A1/es unknown
2003
- 2003-08-20 US US10/644,579 patent/US20040192765A1/en not_active Abandoned
- 2003-08-20 US US10/644,588 patent/US20040192766A1/en not_active Abandoned
- 2003-08-20 US US10/644,587 patent/US20040198811A1/en not_active Abandoned
- 2003-08-20 US US10/644,576 patent/US20040192764A1/en not_active Abandoned
- 2003-08-20 US US10/644,577 patent/US20040198810A1/en not_active Abandoned
- 2003-09-11 ZA ZA200307102A patent/ZA200307102B/xx unknown
- 2003-09-15 IS IS6954A patent/IS6954A/is unknown
- 2003-10-09 NO NO20034538A patent/NO20034538D0/no not_active Application Discontinuation
- 2003-11-24 BG BG108379A patent/BG108379A/bg unknown
2007
- 2007-09-12 US US11/853,949 patent/US20080004338A1/en not_active Abandoned
2008
- 2008-03-21 AT AT0017508U patent/AT10974U1/de not_active IP Right Cessation

Also Published As

Publication number	Publication date
BR0208283A (pt)	2004-03-09
AR033308A1 (es)	2003-12-10
EP1385503A1 (en)	2004-02-04
HUP0400054A3 (en)	2007-03-28
MXPA03008777A (es)	2004-02-12
JP2004527551A (ja)	2004-09-09
US20040192764A1 (en)	2004-09-30
CZ20033267A3 (en)	2004-06-16
IL158031A0 (en)	2004-03-28
CA2445843A1 (en)	2002-11-07
HUP0400054A2 (hu)	2004-04-28
UA82828C2 (en)	2008-05-26
NO20034538D0 (no)	2003-10-09
US20080004338A1 (en)	2008-01-03
ZA200307102B (en)	2004-09-13
PL367480A1 (en)	2005-02-21
US20040192766A1 (en)	2004-09-30
SK14612003A3 (sk)	2004-04-06
US20040198809A1 (en)	2004-10-07
KR20100012089A (ko)	2010-02-05
HRP20030744A2 (en)	2005-06-30
CN1509169A (zh)	2004-06-30
KR20040030609A (ko)	2004-04-09
US20040198811A1 (en)	2004-10-07
AT10974U1 (de)	2010-02-15
YU85303A (sh)	2006-05-25
WO2002087566A1 (en)	2002-11-07
IS6954A (is)	2003-09-15
EA200301195A1 (ru)	2004-04-29
BG108379A (bg)	2004-11-30
MEP5908A (xx)	2010-02-10
US20040192765A1 (en)	2004-09-30
US20040198810A1 (en)	2004-10-07

Legal Events

Date	Code	Title	Description
2008-07-14	CREP	Change of representative	Representative=s name: PLOUGMANN & VINGTOFT, POSTBOKS 1003 SENTRUM, 0104
2011-12-27	FC2A	Withdrawal, rejection or dismissal of laid open patent application

Publication	Publication Date	Title
NO20034538L (no)	2003-10-09	Anvendelsen av enantiomer ren escitalopram
DK1443955T3 (da)	2013-01-02	PDGF-BB til behandling af Parkinsons sygdom
NO20042680L (no)	2004-06-25	Fremgangsmater for fremstilling av O-demetylvenflaxine
NO20031494D0 (no)	2003-04-02	Bestemmelse av brudd-lukningstrykk
DE60202737D1 (de)	2005-03-03	Kappenanordnung
IS6971A (is)	2003-09-29	Ný efnasambönd
DE60215275D1 (de)	2006-11-23	Fahrradscheibenbremsnabe
NO20011272L (no)	2002-07-01	Fremgangsmåte for fremstilling av ren citalopram
NO20011271A (no)	2002-05-13	Fremgangsmåte for fremstilling av ren citalopram
BR0201972B1 (pt)	2012-09-04	montante de suspensão.
NO20040027L (no)	2004-01-05	Fremgangsmate for fremstillingen av escitalopram
LU91603I2 (fr)	2009-10-28	Eslicarbazepine acetate (Zebinix - eslicarbazepineacetate) Composé: énantiomère S de la Licarbazepi ne
DE60224290D1 (de)	2008-02-07	Herstellung von metallrohren
ATE286478T1 (de)	2005-01-15	Verschlusskappe
NO20042667L (no)	2004-06-24	Fremgangsmate for fremstilling av escitalopram
DE50212400D1 (de)	2008-08-07	Lastschaltbare Mehrgangnabe
NO20041200L (no)	2004-03-23	Fremgangsmate for fremstilling av citalopram.
PT1387923E (pt)	2006-09-29	Coroa de perfuracao.
NO20041968L (no)	2004-05-11	Anvendelse av cystationin
NO20042476L (no)	2004-06-14	Anvendelse av desoxypeganin for behandling av klinisk depresjon
DE60126053D1 (de)	2007-03-08	Applikator
EE200400016A (et)	2004-04-15	Protsess 1,5-diarüül-3-trifluorometüül-delta²-pürasoliinide ratseemiliste ja enantiomeerselt puhaste derivaatide valmistamiseks
NO20033163L (no)	2003-07-10	Ny anvendelse av iloperidon
ATA922001A (de)	2002-05-15	Vorsatzschale
DE50204437D1 (de)	2005-11-10	Borstenbremsring